EyeGate Pharmaceuticals Inc (EYEG)

NASDAQ
1.915
-0.035(-1.79%)
  • Volume:
    2,845,763
  • Bid/Ask:
    1.900/1.910
  • Day's Range:
    1.830 - 2.040

EYEG Overview

Prev. Close
1.95
Day's Range
1.83-2.04
Revenue
10K
Open
1.97
52 wk Range
1.44-7.98
EPS
-1.68
Volume
2,845,763
Market Cap
24.61M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,957,274
P/E Ratio
-
Beta
1.06
1-Year Change
-49.87%
Shares Outstanding
12,619,256
Next Earnings Date
Nov 16, 2021
What is your sentiment on EyeGate Pharmaceuticals Inc?
or
Vote to see community's results!

EyeGate Pharmaceuticals Inc News

EyeGate Pharmaceuticals Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuyNeutralStrong Sell
Technical IndicatorsStrong BuyBuyStrong BuyStrong BuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyBuyStrong Sell

EyeGate Pharmaceuticals Inc Company Profile

EyeGate Pharmaceuticals Inc Company Profile

Employees
14

Eyegate Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is engaged in developing and commercializing products for treating inflammatory and immune diseases with a focus on the eye and nervous system. The Company's technology platform, PP-001, is a non-steroidal, immuno-modulatory and small-molecule inhibitor of Dihydroorotate Dehydrogenase (DHODH). PP-001 has been developed in two clinical-stage ophthalmic formulations: PaniJect, is an intravitreal injection for inflammatory diseases of the eye including posterior uveitis, and PaniDrop, is a nano carrier technology eye drop for ocular surface diseases such as conjunctivitis, dry eye disease and others. The Company is also developing Ocular Bandage Gel (OBG), which is a form of the natural polymer hyaluronic acid, designed to protect the ocular surface to permit re-epithelialization of the cornea and improve ocular surface integrity.

Read More
  • hello
    0
    • What happening?
      2
      • seems like it will go up, Insider just purchased more then 150k share: https://www.extrach.com/stock/EYEG
        1
        • Soon $10
          2
          • Perfect time to opt out and all shares are on hold :(
            0
            • Rises on positive study data for eye gel
              0
              • Why is losing to much?
                0
                Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.